Impact Factor
2.34
Journal Citation Impact
Estimated influence, citation density, publishing volume, and citation integrity from the analytics table.
Citation rate
1.07
89 total citations
h5-index
12
h5 depth signal
Cited share
42.7%
38 of 89
Total citations
89
Citation footprint
Metric signal
1.17
External metric anchor
Self-citation
3.4%
3 self-citations
Citations Trend
Monthly Publications Cadence
Citing Geographic Demographics
Spain
211
Argentina
58
United States
10
Brazil
9
Peru
8
Citing Fields of Research
Cardiology
67
Urology
38
Diabetes
28
Autonomic Function
17
Kidney Diseases
15
Publishing Activity & Reach
Volume, recency, access pattern, and citing-community signals from the journal analytics record.
All-time article footprint
1,568
Articles tracked across the journal lifetime
Indexed publication set
89
38 cited publications
Last 12 months
1
1.0 publications/month
Open access share
0.0%
0 OA publications in the last year
Leading citing country
Spain
211 citing publications
Leading citing field
Cardiology
67 citing publications
Latest tracked publication
19 December 2025
10 recent records available
Coverage & Indexing History
v32n1, Jan-Mar 2015-
v32n1, Jan-Mar 2015-
Research Focus & Classification
Indexed Subjects
Cardiology
Autonomic Function
Diabetes
Adrenal Dysfunction
Urology
Nutrition & Dietetics
Issuing & Sponsoring Bodies
Contributor
Sociedad Española de Hipertensión-Liga Española para la Lucha contra la Hipertensión Arterial
Broad Categories
Vascular Diseases
Urology
MeSH Descriptors
Hypertension
Risk Factors
Latest Publications
Recent article records with DOI-first linking and condensed abstracts.
01
DOI 10.1016/j.hipert.2025.12.001
Open DOI
Inflammation in adolescent metabolic syndrome: a call for simplified screening in Latin America
02
DOI 10.1016/j.hipert.2025.04.003
Open DOI
Amlodipine use during pregnancy: Current status in the medical care field in Argentina
Calcium channel blockers (CCBs), such as nifedipine, are commonly used to treat hypertensive disorders of pregnancy (HDP). With the withdrawal of Nifedipine-RETARD and the limitations in compounding formulations, the off-label use of aml...
03
DOI 10.1016/j.hipert.2025.07.002
Open DOI
New nicotine products and vascular risk
Tobacco use is the leading cause of preventable diseases, disability, and death in Spain, causing 56,124 deaths annually, one-third of which are due to cardiovascular disease. The aim of this study is to review the relationship between t...
04
DOI 10.1016/j.hipert.2025.02.003
Open DOI
AHA's new PREVENT 10-year cardiovascular risk and all-cause, CVD, and non-CVD mortality among US adults: The NHANES 2003–2019
The relationship between the American Heart Association's (AHA) new Predicting Risk of cardiovascular disease EVENTs (PREVENT) risk and long-term disease progression, like mortality, is unresolved. We investigated the associations of PRE...
05
DOI 10.1016/j.hipert.2025.04.002
Open DOI
Prevalence of obesity: Comparison of commerce vs. industry sector and associated variables
Obesity has been considered the pandemic of the 21st century due to its high prevalence and the significant morbidity and mortality it entails. The aim of this study is to assess the prevalence of obesity in two occupational sectors and ...
06
DOI 10.1016/j.hipert.2025.02.004
Open DOI
Doctor, what else can I do to avoid having another myocardial infarction?
Patient with classic cardiovascular risk factors under treatment and apparently well controlled, with good adherence to the treatment, but with repeated acute coronary syndromes. After investigating these risk factors, arterial hypertens...
07
DOI 10.1016/j.hipert.2025.03.003
Open DOI
Focal multinodular hepatic steatosis: An uncommon presentation of a known entity
Hepatic steatosis is classified into several types according to its aetiology: metabolic; alcohol-related; metabolic with moderate alcohol consumption; associated with drugs or monogenic diseases, and cryptogenetic. An infrequent form of...
08
DOI 10.1016/j.hipert.2025.04.004
Open DOI
Primary vesicoureteral reflux presenting as hypertensive crisis and thrombotic microangiopathy
A 10-year-old boy with a history of febrile urinary tract infections presented with a hypertensive crisis and thrombotic microangiopathy (TMA). Functional and genetic complement testing was normal, and TMA resolved with blood pressure co...
09
DOI 10.1016/j.hipert.2025.05.001
Open DOI
Mercury poisoning may mimic pheochromocytoma
10
DOI 10.1016/j.hipert.2025.05.002
Open DOI
The sustainability of hypercholesterolemia treatment: New drugs have made such therapy more expensive
Hypercholesterolemia represents a major risk factor in the onset and progression of cardiovascular diseases. While statins have long been the cornerstone of low-density lipoprotein cholesterol (LDL-C) reduction, the occurrence of adverse...
Bibliographical & Catalog Notes
Description based on: Vol. 26, no. 1 (enero/feb. 2009); title from cover.
Latest issue consulted: Vol. 26, no. 1 (enero/feb. 2009).
Also issued online.
In Spanish; abstracts and table of contents also in English.